A report from the American Heart Association Scientific Sessions 2021

Abstract

The present report summarizes the most interesting new clinical studies that were reported during the American Heart Association Scientific Sessions 2021. The AVATAR study evaluated earlier surgical aortic valve replacement. A study by Cardiothoracic Surgical Trials Network focused on concomitant mitral and tricuspid valve surgery. The CRAVE study provided important data for coffee lovers. Use of empagliflozin in heart failure was evaluated in the EMPULSE and EMPEROR-Preserved trials. A study of an oral PCSK9 inhibitor is an initial step towards full evaluation of the efficacy of this drug. Reversal of ticagrelor action was reported in the REVERSE-IT study.